Polymorphisms of the DNA mismatch repair gene HMSH2 in breast cancer occurence and progression

Breast Cancer Research and Treatment

Volumn 94, Issue 3, 2005, Pages 199-204

  Poplawski, Tomasz ^a   Zadrozny, Marek ^b   Kolacinska, Agnieszka ^c   Rykala, Jan ^c   Morawiec, Zbigniew ^c   Blasiak, Janusz ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^c N Copernicus Hospital   (Poland)

Author keywords

Breast cancer; Cancer progression; DNA repair; Gene polymorphism; hMSH2; Mismatch repair; MMR

Indexed keywords

PROTEIN MSH2;

ADULT; ALLELE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CODON; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MISMATCH REPAIR; PERIPHERAL LYMPHOCYTE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR VOLUME;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; DNA REPAIR; FEMALE; GENOTYPE; HUMANS; LYMPHOCYTES; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; PHENOTYPE; POINT MUTATION; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 27944445872     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-4793-7     Document Type: Article

References (46)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M: Cancer statistics. CA Cancer J Clin 51: 15-36, 2001
2. Thomson TA, Hayes MM, Spinelli JJ, Hilland E, Sawrenko C, Phillips D, Dupuis B, Parker RL: HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridisation. Mod Pathol 14: 1079-1086, 2001
3. Gudmundsdottir K, Tryggvadottir L, Eyfjord JE: GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene. Cancer Epidemiol Biomarkers Prev 10: 1169-1173, 2001
4. Yee CJ, Roodi N, Verrier CS, Parl FF: Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res 54: 1641-1644, 1994
5. Shaw JA, Walsh T, Chappell SA, Carey N, Johnson K, Walker RA: Microsatellite instability in early sporadic breast cancer. Br J Cancer 73: 1393-1397, 1996
6. Walsh T, Chappell SA, Shaw JA, Walker RA: Microsatellite instability in ductal carcinoma in situ of the breast. J Pathol 185: 18-24, 1998
7. Loeb LA, Loeb KR, Anderson JP: Multiple mutations and cancer. Proc Natl Acad Sci USA 100: 776-781, 2003
8. Loeb LA: A mutator phenotype in cancer. Cancer Res 61: 3230-3239, 2001
9. Loeb LA: Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54: 5059-5063, 1994
10. Loeb LA: Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51: 3075-3079, 1991
11. Iaccarino I, Palombo F, Drummond J, Totty NF, Hsuan JJ, Modrich P, Jiricny J: MSH6, a Saccharomyces cerevisiae protein that binds to mismatches as a heterodimer with MSH2. Curr. Biol 6: 484-486, 1996
12. Drummond JT, Li GM, Longley MJ, Modrich P: Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science 268: 1909-1912, 1995
13. Macpherson P, Humbert O, Karran P: Frameshift mismatch recognition by the human MutS alpha complex. Mutat Res 408: 55-66, 1998
14. Drummond JT, Genschel J, Wolf E, Modrich P: DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSalpha/hMutSbeta ratio and reduces the efficiency of base-base mismatch repair. Proc Natl Acad Sci USA 94: 10144-10149, 1997
15. Bowers J, Tran PT, Joshi A, Liskay RM, Alani E: MSH-MLH complexes formed at a DNA mismatch are disrupted by the PCNA sliding clamp. J Mol Biol 306: 957-968, 2001
16. Bowers J, Tran PT, Liskay RM, Alani E: Analysis of yeast MSH2-MSH6 suggests that the initiation of mismatch repair can be separated into discrete steps. J Mol Biol 302: 327-338, 2000
17. Guerrette S, Acharya S, Fishel R: The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer. J Biol Chem 274: 6336-6341, 1999
18. Guerrette S, Wilson T, Gradia S, Fishel R: Interactions of human hMSH2 with hMSH3 and hMSH2 with hMSH6: examination of mutations found in hereditary nonpolyposis colorectal cancer. Mol Cell Biol 18: 6616-6623, 1998
19. Wang Y, Friedl W, Lamberti C, Jungck M, Mathiak M, Pagenstecher C, Propping P, Mangold E: Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Int J Cancer 103: 636-641, 2003
20. Xu XS, Narayanan L, Dunklee B, Liskay RM, Glazer PM: Hypermutability to ionizing radiation in mismatch repair-deficient, Pms2 knockout mice. Cancer Res 61 : 3775-3780, 2001
21. Spagnoletti I, Pizzi C, Galietta A, Di MM, Mastranzo P Daniele S, Limite G, Pettinato G, Contegiacomo A: Loss of hMSH2 expression in primary breast cancer with p53 alterations. Oncol Rep 11: 845-851, 2004
22. Cai KQ, Albarracin C, Rosen D, Zhong R, Zheng W, Luthra R, Broaddus R, Liu J: Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma. Hum Pathol 35: 552-559, 2004
23. Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, Taji H, Morishima Y, Emi N, Tajima K: Polymorphism in the hMSH2 gene (gIVS 12-6T->C) and risk of non-Hodgkin lymphoma in a Japanese population. Cancer Genet Cytogenet 147: 71-74, 2003
24. Oliveira C, Ferreira P, Nabais S, Campos L, Ferreira A, Cirnes L, Alves CC, Veiga I, Fragoso M, Regateiro F, Dias LM, Moreira H, Suriano G, Machado JC, Lopes C, Castedo S, Carneiro F, Seruca R: E-cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur J Cancer 40: 1897-1903, 2004
25. Takahashi Y, Kondo K, Hirose T, Nakagawa H, Tsuyuguchi M, Hashimoto M, Sano T, Ochiai A, Monden Y: Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate-exposed workers. Mol Carcinog 10: 147-155, 2004
26. Rajkumar T, Soumittra N, Pandey D, Nancy KN, Mahajan V, Majhi U: Mutation analysis of hMSH2 and hMLH1 in colorectal cancer patients in India. Genet Test 8: 157-162, 2004
27. Roupret M, Catto J, Coulet F, Azzouzi AR, Amira N, Karmouni T, Fromont G, Sibony M, Vallancien G, Gattegno B, Meuth M, Hamdy FC, Cussenot O: Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma. J Med Genet 41: 91-95, 2004
28. Nakata B, Wang YQ, Yashiro M, Ohira M, Ishikawa T, Nishino H, Seki S, Hirakawa K: Negative hMSH2 protein expression in pancreatic carcinoma may predict a better prognosis of patients. Oncol Rep 10: 997-1000, 2003
29. Chung DC, Rustgi AK: The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 138: 560-570, 2003
30. Bock N, Meden H, Regenbrecht M, Junemann B, Wangerin J, Marx D: Expression of the mismatch repair protein hMSH2 in carcinoma in situ and invasive cancer of the breast. Anticancer Res 20: 119-124, 2000
31. Murata H, Khattar NH, Kang Y, Gu L, Li GM: Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with micro satellite instability. Oncogene 21: 5696-5703, 2002
32. Seitz S, Wassmuth P, Plaschke J, Schackert HK, Karsten U, Santibanez-Koref MF, Schlag PM, Scherneck S: Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines. Genes Chromosomes Cancer 37: 29-35, 2003
33. Balogh GA, Russo IH, Russo J: Truncation of the mismatch repair protein PMS2 during the neoplastic transformation of human breast epithelial cells in vitro. Int J Oncol 25: 381-387, 2004
34. Balogh GA, Russo IH, Russo J: Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells. Int J Oncol 23: 411-419, 2003
35. Lippke JA, Strzempko MN, Raia FF, Simon SL, French CK: Isolation of intact high-molecular-weight DNA by using guanidine isothiocyanate. Appl Environ Microbiol 53: 2588-2589, 1987
36. Butkiewicz D, Rusin M, Enewold L, Shields PG, Chorazy M, Harris CC: Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 22: 593-597, 2001
37. Starinsky S, Figer A, Ben-Asher E, Geva R, Flex D, Fidder HH, Zidan J, Lancet D, Friedman E: Genotype phenotype correlations in Israeli colorectal cancer patients. Int J Cancer 114: 58-73, 2005
38. Sud R, Wells D, Talbot IC, Delhanty JD: Genetic alterations in gastric cancers from British patients. Cancer Genet Cytogenet 126: 111-119, 2001
39. Worrillow LJ, Travis LB, Smith AG, Rollinson S, Smith AJ, Wild CP, Holowaty EJ, Kohler BA, Wiklund T, Pukkala E, Roman E, Morgan GJ, Allan JM: An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents. Clin Cancer Res 9: 3012-3020, 2003
40. Jiricny J: Eukaryotic mismatch repair: an update. Mutat Res 409: 107-121, 1998
41. Wang Q, Zhang H, Guerrette S, Chen J, Mazurek A, Wilson T, Slupianek A, Skorski T, Fishel R, Greene MI: Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1. Oncogene 20: 4640-4649, 2001
42. Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM: Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90: 425-435, 1997
43. van Hoffen A, Balajee AS, van Zeeland AA, Mullenders LH: Nucleotide excision repair and its interplay with transcription. Toxicology 193: 79-90, 2003
44. Mellon I, Rajpal DK, Koi M, Boland CR, Champe GN: Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science 272: 557-560, 1996
45. Yang Q, Nakamura Y, Nakamura M, Yoshimura G, Suzuma T, Umemura T, Mori I, Sakurai T, Kakudo K: Loss of Msh2 is not associated with FHIT deletion in breast carcinomas. Anticancer Res 22: 2591-2595, 2002
46. Young LC, Hays JB, Tron VA, Andrew SE: DNA mismatch repair proteins: potential guardians against genomic instability and tumorigenesis induced by ultraviolet photoproducts. J Invest Dermatol 121: 435-440, 2003